Suchergebnisse - "Winterberg, Markus"

PubPharm (53)

11

Differential Impact of Nevirapine on Artemether-Lumefantrine Pharmacokinetics in Individuals Stratified by CYP2B6 c.516G>T Genotypes

enthalten in: Antimicrobial agents and chemotherapy | 2020

von Abdullahi, S. | Soyinka, J. | Olagunju, A. | +7

12

Drug Interactions Between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine

enthalten in: bioRxiv.org | 2020

von Walimbwa, S. | Lamorde, M. | Waitt, C. | +9

13

Combining antimalarial drugs and vaccine for malaria elimination campaigns : a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers

enthalten in: Human vaccines & immunotherapeutics | 2020

von von Seidlein, L. | Hanboonkunupakarn, B. | Jittamala, P. | +19

14

Adherence and Population Pharmacokinetic Properties of Amodiaquine When Used for Seasonal Malaria Chemoprevention in African Children

enthalten in: Clinical Pharmacology & Therapeutics | 2020

von Ding, J. | Coldiron, M. | Assao, B. | +7

15

Safety, Pharmacokinetics, and Mosquito‐Lethal Effects of Ivermectin in Combination With Dihydroartemisinin‐Piperaquine and Primaquine in Healthy Adult Thai Subjects

enthalten in: Clinical Pharmacology & Therapeutics | 2020

von Kobylinski, K. | Jittamala, P. | Hanboonkunupakarn, B. | +12

16

CYP2B6*6 Genotype Specific Differences in Artemether‐Lumefantrine Disposition in Healthy Volunteers

enthalten in: The Journal of Clinical Pharmacology | 2020

von Abdullahi, S. | Soyinka, J. | Olagunju, A. | +7

17

Prospective Clinical and Molecular Evaluation of Potential Plasmodium ovale curtisi and wallikeri Relapses in a High-transmission Setting

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019

von Groger, M. | Veletzky, L. | Lalremruata, A. | +15

CommentIn: Clin Infect Dis. 2020 Apr 15;70(9):2018-2019. - PMID 31408098

18

Mass spectrometry-based proteomic techniques to identify cerebrospinal fluid biomarkers for diagnosing suspected central nervous system infections. A systematic review

enthalten in: The Journal of infection | 2019

von Bharucha, T. | Gangadharan, B. | Kumar, A. | +5

CommentIn: J Infect. 2020 Jul;81(1):147-178. - PMID 32092389

19

Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam : a prospective clinical, pharmacological, and genetic study

enthalten in: The Lancet. Infectious diseases | 2019

von van der Pluijm, R. | Imwong, M. | Chau, N. | +42

CommentIn: Lancet Infect Dis. 2019 Sep;19(9):916-917. - PMID 31345711

20

Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults

enthalten in: Antimicrobial agents and chemotherapy | 2019

von Hanboonkunupakarn, B. | van der Pluijm, R. | Hoglund, R. | +10